Perform Another (Advanced) Search

1.  Study Posting (1918) Trial #158890, Endometrial Cancer, Savannah, GA
...Study Posting (1918) Trial #158890, Endometrial Cancer, Savannah, GA Trial Information Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer RATIONALE : Temsirolimus may ...
...for cell growth. Estrogen can cause the growth of endometrial cancer cells. Hormone therapy using megestrol and tamoxifen may fight endometrial cancer by blocking the use of estrogen by the tumor ...
View Page

2.  Study Posting (1918) Trial #158900, Endometrial Cancer, Savannah, GA
...Study Posting (1918) Trial #158900, Endometrial Cancer, Savannah, GA Trial Information Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer To estimate the ...
...Memorial Health University Medical Center support@centerwatch.com sharppa1@memorialhealth.com Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer Endometrial Cancer Savannah ...
View Page

3.  Newly Approved Drug Therapies (587) Aromasin Tablets, Pharmacia & Upjohn,
...and the risk of death by 23 percent, is more beneficial than the hormone therapy, megestrol acetate. In post-menopausal women, the principle source of estrogen comes from the conversion of ...
...breast cancer had metastasized (spread). The study compared the effects of Aromasin versus those of megestrol acetate on survival, tumor reduction, and duration of disease stabilization. Patients taking megestrol acetate had ...
View Page

4.  Study Posting (1918) Trial #85467, Adenocarcinoma, Savannah, GA
...serum PSA, or • Non-measurable disease w/PSA > 5ng/ml. Patient Exclusion Criteria: • Flutamide and megestrol acetate must be discontinued > 4 wks before registration (> 6 wks pre-regist for bicalutamide and ...
...4 wks since any other hormonal therapy, including ketoconazole, aminoglutethimide, systemic steroids (any dose), or megestrol acetate . • No prior cytotoxic chemo, including estramustine or suramin. • No prior anti-angiogenesis agents, including ...
View Page

5.  Study Posting (1918) Trial #117498, Breast Cancer, Savannah, GA
...radiation, endocrine therapy, chemotherapy, or investigational agent • Has received hormone replacement therapy of any type, megestrol acetate, or raloxifene within one week prior to registration • Has distal metastasis (M1), excluding isolated ...
View Page

6.  CenterWatch: Clinical Trials in Category (32) Endometrial Cancer
...or Stage II Endometrial Cancer Savannah : Memorial Health University Medical Center Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer Illinois Hinsdale : Hinsdale ...
View Page

7.  CenterWatch Clinical Research Profile (1918) Trial #937, Memorial Health University Medical Center, Savannah, GA
...Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma • Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer • The Effect Of ...
View Page